Paragon Fine
Paragon Fine Q4 FY26: Revenue ₹68.88 Cr, PAT ₹7.06 Cr
Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.
Paragon Fine Q4 FY26 key numbers
- Revenue
- Revenue for H2FY26: Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25.
As stated in Paragon Fine's Q4 FY26 investor presentation · published 16 Oct 2026. Reported figures, not investment advice.
Based on Paragon Fine's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue for H2FY26: Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Quarter (H2 FY26) Financials: - EBITDA: Rs 9.83 Cr, up 62.21% YoY (H2 FY25: Rs 6.06 Cr) - EBITDA Margin: 14.27% (H2 FY25: 9.5%) - PAT: Rs 7.06 Cr, up 67.69% YoY (H2 FY25: Rs 4.21 Cr) - PAT Margin: 10.25% (H2 FY25: 6.6%) - Margin Outlook: - Presentation highlights ongoing margin expansion, with EBITDA margin growing from 7.1% in FY22 to 11.6% in FY26.
From Paragon Fine's Q4 FY26 earnings-call transcript · updated 16 Oct 2026.
Revenue & Sales Performance
- Revenue for H2FY26: Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22).
- Revenue for FY26: Rs 109.98 Cr, down 5.27% YoY from Rs 116.1 Cr in FY25 (Page 22).
- Volume/Capacity: Current capacity at 650 MTPA with ongoing expansion (Page 6).
- Specific product volume: HALQUINOL production reached 100 MTPA, targeting at least 150 MTPA (Page 6).
2 more points from Paragon Fine's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Paragon Fine said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current plant capacity is 650 MTPA with ongoing expansion while the plant remains operational (Page 6, 5).
- Introduction of HALQUINOL product targeting 10,000 MTPA addressable market; planned production of at least 150 MTPA; operational achievement of 100 MTPA HALQUINOL (Page 6, 5).
- Plan to develop a Clean Room Facility for multi-purpose use (Pharma, Cosmetics, Electronics) post expansion completion (Page 6, 5).
- Utilization of IPO proceeds for scaling up operational and product expansion mentioned (Page 18, 19).
2 more points from Paragon Fine's call on capex
Create a free account to keep reading this call
Fundraising & Capital Structure
See what Paragon Fine said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Continue your research
Others in Chemicals & Petrochemicals this season
- Indian Phosphate Ltd (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- IVP Ltd (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals Ltd (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
- Mangalam Organic (Q4 FY26)
153.62 Cr . Key investor presentation takeaways from Mangalam Organic's Q4 FY26 investor presentation — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Paragon Fine and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Paragon Fine Q4 FY26 results?
Revenue for H2FY26: Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Quarter (H2 FY26) Financials: - EBITDA: Rs 9.83 Cr, up 62.21% YoY (H2 FY25: Rs 6.06 Cr) - EBITDA Margin: 14.27% (H2 FY25: 9.5%) - PAT: Rs 7.06 Cr, up 67.69% YoY (H2 FY25: Rs 4.21 Cr) - PAT Margin: 10.25% (H2 FY25: 6.6%) - Margin Outlook: - Presentation highlights ongoing margin expansion, with EBITDA margin growing from 7.1% in FY22 to 11.6% in FY26.
What is Paragon Fine share price analysis?
Paragon Fine currently shows a neutral. The stock trades at a P/E of 10.9 with a market cap of ₹98 Cr. Investors should review the full earnings analysis for detailed insights.
Is Paragon Fine planning capital expenditure?
Current plant capacity is 650 MTPA with ongoing expansion while the plant remains operational (Page 6, 5). - Introduction of HALQUINOL product targeting 10,000 MTPA addressable market; planned production of at least 150 MTPA; operational achievement of 100 MTPA HALQUINOL (Page 6, 5). - Plan to develop a Clean Room Facility for multi-purpose use (Pharma, Cosmetics, Electronics) post expansion completion (Page 6, 5). - Utilization of IPO proceeds for scaling up operational and product expansion mentioned (Page 18, 19). - Capex for FY26 was Rs.
Keep Paragon Fine on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
